Revlimid Side Effects
View Community-reported Revlimid side effects
Add Your Side Effect to the Community Database
Help Community - Describe Your Revlimid Side Effect
Have You dealt with a Revlimid side effect? Share your experience
Revlimid Side Effects summary
Total Revlimid reports: 5063.Revlimid FDA safety alerts: No.
Reported deaths: 1967 Reported hospitalizations: 1610.
Take Revlimid Side Effects Survey, Discuss Revlimid with others
Revlimid Side Effects: death, disease progression, multiple myeloma, malignant neoplasm progression, fatigue, myelodysplastic syndrome, platelet count decreased, asthenia, pancytopenia, thrombocytopenia, white blood cell count decreased,
Revlimid Usage.
If you have questions about Revlimid, you can ask a Health Expert or Ask Patient Community about Revlimid.
Revlimid Side Effects reported to FDA
< Previous Showing 121-160 of 5063 Next >
Revlimid Side Effects Report #5678022-2Physician from UNITED STATES reported REVLIMID problem on Mar 14, 2008. Male patient was diagnosed with prostate cancer and was treated with REVLIMID. REVLIMID dosage: unknown. Patient died.
Revlimid Side Effects Report #5678024-6
REVLIMID problem was reported by a Health Professional from UNITED STATES on Mar 14, 2008. Male patient, 69 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. REVLIMID dosage: 25 MG, 1 IN 1 D, ORAL. Patient died.
Revlimid Side Effects Report #5678026-X
Physician from UNITED STATES reported REVLIMID problem on Mar 12, 2008. Male patient was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. REVLIMID dosage: 10 MG, 1 IN 1 D, ORAL, 5 MG, 1 IN 1 D, ORAL. Patient died.
Revlimid Side Effects Report #5678028-3
REVLIMID problem was reported by a Physician from UNITED STATES on Mar 12, 2008. Male patient was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: arrhythmia, asthenia, immune system disorder, nasopharyngitis, pneumonia, pyrexia. REVLIMID dosage: 25-10MG, DAILY, ORAL, 5 MG, 1 IN 1 D, ORAL. Patient was hospitalized. Patient recovered.
Revlimid Side Effects Report #5678036-2
Consumer or non-health professional from UNITED STATES reported REVLIMID problem on Mar 12, 2008. Female patient was diagnosed with mantle cell lymphoma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: diplopia, loss of consciousness, vertigo. REVLIMID dosage: unknown. During the same period patient was treated with RITUXIMAB. Patient recovered.
Revlimid Side Effects Report #5678216-6
REVLIMID problem was reported by a Pharmacist from UNITED STATES on Mar 24, 2008. Female patient was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: disease progression, interstitial lung disease, thrombocytopenia. REVLIMID dosage: 25MG DAILY 21D/28D PO. During the same period patient was treated with DEXAMETHASONE, OMEPRAZOLE, CIPRO, AREDIA. Patient was hospitalized. Patient recovered.
Revlimid Side Effects Report #5678243-9
Physician from SWITZERLAND reported REVLIMID problem on Mar 12, 2008. Male patient was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: leukopenia, pneumonia. REVLIMID dosage: unknown. During the same period patient was treated with DEXAMETHASONE, ANTICOAGULANTS. Patient was hospitalized. Patient died on 12/31/2007.
Revlimid Side Effects Report #5678244-0
REVLIMID problem was reported by a Health Professional from GERMANY on Mar 13, 2008. Female patient, 70 years of age, was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: haemoglobin decreased, platelet count decreased, sepsis. REVLIMID dosage: 15 MG, ORAL; 8 MG, 1-4, 9-12. During the same period patient was treated with DEXAMETHASONE. Patient was hospitalized. Patient died on 03/11/2008.
Revlimid Side Effects Report #5678246-4
Physician from AUSTRIA reported REVLIMID problem on Mar 12, 2008. Male patient, 75 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: pelvic venous thrombosis, pulmonary embolism. REVLIMID dosage: 10 MG D1-21, ORAL; 25-15MG, QD D1-21, ORAL. During the same period patient was treated with ACETYLSALICYLIC ACID SRT, DEXAMETHASONE. Patient died on 03/02/2008.
Revlimid Side Effects Report #5678253-1
REVLIMID problem was reported by a Physician from AUSTRIA on Mar 14, 2008. Female patient, 67 years of age, weighting 167.6 lb, was diagnosed with 5q-syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: anaemia haemolytic autoimmune, condition aggravated, neutropenia, thrombocytopenia. REVLIMID dosage: 10 MG, DAILY; ORAL, 5 MG, DAILY X 21 DAYS PER 28 DAY CYCLE, ORAL, 5 MG, EVERY OTHER DAY, ORAL. During the same period patient was treated with ENOXAPARIN NATRIUM, LMW HEPARIN, LOVENOX, EXJADE. Patient recovered.
Revlimid Side Effects Report #5678321-4
Health Professional from UNITED STATES reported REVLIMID problem on Mar 13, 2008. Male patient, 57 years of age, weighting 217.2 lb, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: anaemia, carpal tunnel syndrome, neuralgia, neuropathy peripheral, renal failure acute. REVLIMID dosage: 25 MG, QD ON DAYS 1-21, EVERY 28 DAYS, ORAL, 25 MG, QD ON DAYS 1-21 EVERY 28 DAYS, ORAL. During the same period patient was treated with DEXAMETHASONE. Patient recovered.
Revlimid Side Effects Report #5678323-8
REVLIMID problem was reported by a Physician from UNITED STATES on Mar 14, 2008. Male patient, 73 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: cardiac failure congestive. REVLIMID dosage: 15 MG, 1 IN 1 D, ORAL. Patient was hospitalized. Patient died on 01/01/2008.
Revlimid Side Effects Report #5678324-X
Consumer or non-health professional from UNITED STATES reported REVLIMID problem on Mar 17, 2008. Female patient, 65 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. REVLIMID dosage: 15 MG, 1 IN 1 D, ORAL. Patient died on 01/01/2008.
Revlimid Side Effects Report #5678325-1
REVLIMID problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 17, 2008. Male patient, 82 years of age, was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. REVLIMID dosage: 10 MG, 1 IN 1 D, ORAL. Patient died on 03/01/2008.
Revlimid Side Effects Report #5678326-3
Consumer or non-health professional from UNITED STATES reported REVLIMID problem on Mar 13, 2008. Male patient, 63 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: cardiac arrest. REVLIMID dosage: 10 MG, 1 IN 1D, ORAL. Patient died on 03/05/2008.
Revlimid Side Effects Report #5678327-5
REVLIMID problem was reported by a Health Professional from UNITED STATES on Mar 13, 2008. Female patient, 77 years of age, weighting 145.5 lb, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, extraocular muscle disorder, fatigue, muscular weakness. REVLIMID dosage: 25 MG, QD ON DAYS 1-21, EVERY 28, ORAL. During the same period patient was treated with DEXAMETHASONE. Patient recovered.
Revlimid Side Effects Report #5678329-9
Consumer or non-health professional from UNITED STATES reported REVLIMID problem on Mar 14, 2008. Male patient, 71 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: apnoea, swelling. REVLIMID dosage: 25 MG, 1 IN 1 D, ORAL. Patient recovered.
Revlimid Side Effects Report #5678330-5
REVLIMID problem was reported by a Physician from UNITED STATES on Mar 17, 2008. Female patient, 94 years of age, was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. REVLIMID dosage: 10 MG, 1 IN 1 D, ORAL. Patient died on 12/29/2007.
Revlimid Side Effects Report #5678331-7
Physician from UNITED STATES reported REVLIMID problem on Mar 17, 2008. Male patient, 80 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, non-hodgkin's lymphoma, rash, red blood cell count decreased. REVLIMID dosage: 10 MG - 25 MG, QD, ORAL; 20 MG, X21 DAYS EVERY 28 DAYS, ORAL. Patient died on 02/07/2008.
Revlimid Side Effects Report #5678332-9
REVLIMID problem was reported by a Physician from UNITED STATES on Mar 17, 2008. Male patient, 75 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, multiple myeloma. REVLIMID dosage: 25 MG, 1 IN 1 D, ORAL; 10 MG, 1 IN 1 D, ORAL. Patient died.
Revlimid Side Effects Report #5678334-2
Physician from UNITED STATES reported REVLIMID problem on Mar 17, 2008. Female patient, 73 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, multiple myeloma. REVLIMID dosage: 15 MG, 1 IN 1 D, ORAL. Patient died on 01/04/2008.
Revlimid Side Effects Report #5678335-4
REVLIMID problem was reported by a Physician from UNITED STATES on Mar 17, 2008. Female patient, 74 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: arthralgia, dizziness, fatigue, hypotension, malaise, muscular weakness, nausea, pyrexia. REVLIMID dosage: 25 MG, DAILY X 21D Q28D, ORAL. During the same period patient was treated with AREDIA. Patient was hospitalized. Patient died on 12/03/2007.
Revlimid Side Effects Report #5678337-8
Physician from UNITED STATES reported REVLIMID problem on Mar 17, 2008. Female patient, 59 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, multiple myeloma. REVLIMID dosage: 25 MG, 1 IN 1 D, ORAL. Patient died on 02/01/2008.
Revlimid Side Effects Report #5678387-1
REVLIMID problem was reported by a Physician from SWITZERLAND on Mar 17, 2008. Female patient was diagnosed with 5q-syndrome, acute myeloid leukaemia and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: inflammation. REVLIMID dosage: 10 MG, ORAL. During the same period patient was treated with ANTIBIOTIC. Patient died.
Revlimid Side Effects Report #5678390-1
Physician from NETHERLANDS reported REVLIMID problem on Mar 13, 2008. Female patient, 66 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: humerus fracture, pathological fracture. REVLIMID dosage: 15 MG, 2 IN 1 D, ORAL; 25 MG, 1 IN 1 D, ORAL. Patient was hospitalized. Patient recovered.
Revlimid Side Effects Report #5678395-0
REVLIMID problem was reported by a Health Professional from SWITZERLAND on Mar 12, 2008. Male patient, 61 years of age, was diagnosed with myeloma recurrence and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: arterial stenosis, carotid artery thrombosis, ejection fraction decreased. REVLIMID dosage: 25 MG, 1-0-0, DAY 1-21, ORAL. During the same period patient was treated with DEXAMETHASONE, ADRIAMYCIN PFS, DICLOFENAC, ASPIRIN, PLAVIX, PRINIL, NEBIVOLOL, ATORVASTATIN CALCIUM. Patient was hospitalized. Patient recovered.
Revlimid Side Effects Report #5678685-1
Health Professional from UNITED STATES reported REVLIMID problem on Mar 13, 2008. Female patient, 83 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: vaginal haemorrhage. REVLIMID dosage: 25 MG, 1 IN 1 D, ORAL. During the same period patient was treated with CALCIUM, CENTRUM, SENNA, ASPIRIN, ZANTAC, FENTANYL, ANTIEMETIC. Patient recovered.
Revlimid Side Effects Report #5678687-5
REVLIMID problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 13, 2008. Male patient, 62 years of age, was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: respiratory disorder. REVLIMID dosage: 10 MG, 1 IN 1 D, ORAL. Patient was hospitalized. Patient recovered.
Revlimid Side Effects Report #5678688-7
Physician from UNITED STATES reported REVLIMID problem on Mar 05, 2008. Female patient, 68 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: non-hodgkin's lymphoma. REVLIMID dosage: 25 MG, DAILY FOR 21 DAYS, ORAL. Patient recovered.
Revlimid Side Effects Report #5678689-9
REVLIMID problem was reported by a Physician from UNITED STATES on Mar 17, 2008. Male patient, 63 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: disease progression, multiple myeloma. REVLIMID dosage: 10-5MG, DAILY, ORAL. Patient died.
Revlimid Side Effects Report #5679155-7
Physician from FRANCE reported REVLIMID problem on Mar 13, 2008. Male patient, 56 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: enterocolitis haemorrhagic, gastritis. REVLIMID dosage: 25 MG, DAILY, ORAL. Patient was hospitalized. Patient recovered.
Revlimid Side Effects Report #5679367-2
REVLIMID problem was reported by a Health Professional from GERMANY on Mar 11, 2008. Male patient, 80 years of age, weighting 158.7 lb, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: cholestasis. REVLIMID dosage: 25 MG, ORAL. Patient was hospitalized. Patient recovered.
Revlimid Side Effects Report #5679368-4
Consumer or non-health professional from FRANCE reported REVLIMID problem on Mar 14, 2008. Male patient, 77 years of age, was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: cardiac disorder, pulmonary fibrosis. REVLIMID dosage: unknown. Patient recovered.
Revlimid Side Effects Report #5679660-3
REVLIMID problem was reported by a Physician from UNITED STATES on Mar 17, 2008. Male patient, 59 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: dermatitis, disease progression, rash. REVLIMID dosage: 25 MG, QD X21 DAYS, ORAL. During the same period patient was treated with DEXAMETHASONE, VELCADE, ALLOPURINOL. Patient died on 12/01/2007.
Revlimid Side Effects Report #5679662-7
Consumer or non-health professional from UNITED STATES reported REVLIMID problem on Mar 17, 2008. Male patient, 78 years of age, was diagnosed with lymphoma and was treated with REVLIMID. REVLIMID dosage: 15 MG, 1 IN 1 D, ORAL. Patient died on 03/01/2008.
Revlimid Side Effects Report #5679664-0
REVLIMID problem was reported by a Physician from UNITED STATES on Mar 14, 2008. Female patient was diagnosed with neoplasm, prostate cancer and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: arrhythmia, haemolysis, neutropenia. REVLIMID dosage: 5MG-40MG, 21 DAYS ON, 7 DAYS OFF, ORAL. During the same period patient was treated with KETOCONAZOLE, HYDROCORTISONE. Patient recovered.
Revlimid Side Effects Report #5679667-6
Health Professional from UNITED STATES reported REVLIMID problem on Mar 17, 2008. Male patient, 62 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. REVLIMID dosage: 15 MG, DAILY FOR 21 DAYS, ORAL; 25 MG, DAILY FOR 21 DAYS, ORAL. Patient died on 03/15/2008.
Revlimid Side Effects Report #5679669-X
REVLIMID problem was reported by a Physician from UNITED STATES on Mar 17, 2008. Male patient, 60 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. REVLIMID dosage: 25 MG, 1 IN 1 D, ORAL. Patient died on 01/01/2007.
Revlimid Side Effects Report #5679670-6
Physician from UNITED STATES reported REVLIMID problem on Mar 17, 2008. Male patient, 61 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, multiple myeloma. REVLIMID dosage: 25 MG, 1 IN 1 D, ORAL. Patient died on 01/01/2007.
Revlimid Side Effects Report #5679672-X
REVLIMID problem was reported by a Physician from UNITED STATES on Mar 17, 2008. Female patient, 55 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: disease progression. REVLIMID dosage: 25 MG, QD, ORAL. Patient died.
< Previous Showing 121-160 of 5063 Next >